Company intelligence / Profile preview
Ribozyome
Boulder, Colorado, United Statesrpi.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company had several products in clinical trials, including an anti-Hepatitis C virus ribozyme partnered with Eli Lilly, and Angiozyme (an anti-angiogenic ribozyme) in Phase I/II trials for cancer patients at the Cleveland Clinic. They also had Herzyme, targeting HER-2 for breast and ovarian cancer treatment, in pre-clinical studies.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- RNA-based therapeuticsribozymes
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Eli LillyChiron CorporationMedizyme Pharmaceuticals (joint venture with Elan Corp affiliate)
Beyond the preview
Go deeper on Ribozyome.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribozyome.